TherapeuticsMD (TXMD) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2023)
Powered by 
Analysis
TherapeuticsMD (TXMD) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2023) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn | 4.65% |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn | 5.45% |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn | 5.00% |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn | -0.43% |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn | 2.85% |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn | 7.03% |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn | 3.06% |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - | - |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn | 16.78% |
| 10 | TherapeuticsMD | 25.35 Mn | 16.16 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2023 | -78.71% |
| Jun 30, 2023 | -73.71% |
| Mar 31, 2023 | -70.80% |
| Dec 31, 2022 | -68.55% |
| Sep 30, 2022 | -38.23% |
| Jun 30, 2022 | -20.85% |
| Dec 31, 2021 | 20.30% |
| Sep 30, 2021 | 53.75% |
| Jun 30, 2021 | 59.80% |
| Mar 31, 2021 | 62.08% |
| Dec 31, 2020 | 64.40% |
| Sep 30, 2020 | 63.82% |
| Jun 30, 2020 | 64.32% |
| Mar 31, 2020 | 65.82% |
| Dec 31, 2019 | 69.30% |
| Sep 30, 2019 | 71.87% |
| Jun 30, 2019 | 47.71% |
| Dec 31, 2018 | 33.52% |
| Sep 30, 2018 | 88.80% |
| Dec 31, 2017 | 90.43% |